BridgeMD
New treatment option for Neuropathic Pain
Official title Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function.
ClinicalTrials.gov ID: NCT07403331
What this study is testing
- What it's testing
- People with nerve damage can develop nerve pain. The pain can sometimes be severe and unpredictable, causing odd or alarming sensations - for example, lightning-like or electric shock feelings in the area served by the damaged nerve.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Peripheral neuropathic pain in one or both legs for \>6 months due to:
- (1) Post Spinal Pain Syndrome (type 1 or 2).
- (2) Localized nerve damage.
- The area of the neuropathic pain in the leg(s) must be the dominant pain component.
- Age ranges from 18-60 years.
You likely can't join if
- Currently undergoing the claims process for health benefits (e.g., disability pensions from NAV (Norwegian Labour and Welfare Administration).
- Presenting a psychological or psychiatric disorder that may impact treatment how well it works.
- Chronic generalized pain conditions.
- Other pain conditions in the affected area, such as osteoarthritis.
- Pregnancy.
See the full eligibility criteria
- Peripheral neuropathic pain in one or both legs for \>6 months due to:
- (1) Post Spinal Pain Syndrome (type 1 or 2).
- (2) Localized nerve damage.
- The area of the neuropathic pain in the leg(s) must be the dominant pain component.
- Age ranges from 18-60 years.
- Previous standard conservative (or surgical) treatment attempted.
- Opioid use within permissible limits at implantation time (daily opioid dose \<50 mg OMEQ).
- Willingness to actively participate in the treatment bundle.
- Living within reasonable travelling distance from Oslo.
- Proficiency in understanding oral and written Norwegian, essential to benefit from the program that relies on mutual comprehension, nuanced conversation, and emotional expression, which are language-dependent.
- Cognitive capacity to provide informed consent.
- Ability to master the technical aspects of the SCS system (switching programs on the remote control).
- Currently undergoing the claims process for health benefits (e.g., disability pensions from NAV (Norwegian Labour and Welfare Administration).
- Presenting a psychological or psychiatric disorder that may impact treatment how well it works.
- Chronic generalized pain conditions.
- Other pain conditions in the affected area, such as osteoarthritis.
- Pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.